Cargando…
Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review
SIMPLE SUMMARY: Despite rapid advances in the development of novel agents over the last decade for the treatment of multiple myeloma (MM), MM remains an incurable disease. Therefore, the development of novel targeting therapies with different mechanisms of action is needed to achieve a deep and dura...
Autor principal: | Nishida, Hiroko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198014/ https://www.ncbi.nlm.nih.gov/pubmed/34072645 http://dx.doi.org/10.3390/cancers13112712 |
Ejemplares similares
-
Bone-targeted agents in multiple myeloma
por: Nishida, Hiroko
Publicado: (2018) -
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review
por: Ismail, Nor Hayati, et al.
Publicado: (2023) -
Immunotherapy for Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2019) -
Immunotherapy in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2020) -
The Role of Immunotherapy in Multiple Myeloma
por: Kocoglu, Mehmet, et al.
Publicado: (2016)